Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway

Table 1 Correlation between GOLPH3 protein expression and clinicopathological characteristics of hepatocellular carcinoma

Clinicopathological characteristics	Number of cases	GOLPH3 expression		P-value
		Low	High
Gender				0.288
Male	39	14	25
Female	21	4	17
Age(years)				0.302
≤50	26	6	20
>50	34	12	22
Tumor size				0.220
≤5 cm	38	14	24
>5 cm	22	4	18
AFP levels				0.006(*)
≤20 ng/ml	21	11	10
>20 ng/ml	39	7	32
HBsAg				0.1
negative	27	11	16
positive	33	7	26
Vascular invasion				0.186
Absence	36	8	28
Presence	24	10	14
Liver cirrhosis				0.071
Absence	31	13	18
Presence	29	5	24

P-value was calculated by using chi-square test. *P < 0.05 indicates a significant association among the variables

ISSN: 1471-2407